SYNDYMA
Cipla's U-turn: Happily ever after?In a foes-turn-friends move announced on February 27, the Mumbai-based drug maker announced that it will partner Swiss biotech company Roch...
Roche and Cipla tie up to market anti cancer drugsRoche said this partnership will also enable it to focus on bringing new, transformative medicines to patients in India.
Top stocks in focus on 28 February 2018Here is a list of top stocks that are likely to be in focus in today's trading session.
Cipla ties up with Roche to sell 2 cancer drugs in IndiaThe pharma major will distribute Tocilizumab and Syndyma -- the second brand of Roche's cancer therapy bevacizumab -- in India.
Load More